Last reviewed · How we verify
sugar pill, saline infusion
A placebo control consisting of inert sugar or saline that produces no pharmacological effect, used as a comparator in clinical trials.
A placebo control consisting of inert sugar or saline that produces no pharmacological effect, used as a comparator in clinical trials. Used for Clinical trial control arm (non-therapeutic use).
At a glance
| Generic name | sugar pill, saline infusion |
|---|---|
| Also known as | Laktose monohydrat, NaCl 0,9% |
| Sponsor | Oslo University Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Mechanism of action
Sugar pills and saline infusions are inert substances with no active pharmaceutical mechanism. They are used in randomized controlled trials as placebo controls to measure the effect of an investigational drug against baseline or natural disease progression, accounting for placebo response and observer bias.
Approved indications
- Clinical trial control arm (non-therapeutic use)
Common side effects
- Placebo response (symptom improvement unrelated to pharmacology)
Key clinical trials
- Mechanisms of Cerebrovascular Control (PHASE1)
- Feasibility of a Clinical Trial Comparing the Use of Cetirizine to Replace Diphenhydramine in the Prevention of Reactions Related to Paclitaxel (PHASE3)
- Imaging Pain Relief in Osteoarthritis (PHASE4)
- Pregabalin and Remifentanil - Analgesia and Ventilation (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- sugar pill, saline infusion CI brief — competitive landscape report
- sugar pill, saline infusion updates RSS · CI watch RSS
- Oslo University Hospital portfolio CI